What Happened
- Researchers led by Professor Justin Chalker at Flinders University (Australia), in collaboration with scientists from the University of Liverpool and international partners, have discovered a previously unknown chemical reaction: the trisulfide metathesis reaction.
- Published in the journal Nature Chemistry (2026), the reaction describes how molecules containing chains of three sulphur atoms (trisulfides) spontaneously exchange sulphur-sulphur bonds at room temperature without requiring any additional reagents, catalysts, heat, or light.
- The team demonstrated the reaction's pharmaceutical application by selectively modifying calicheamicin — a powerful anti-tumour compound used in targeted cancer therapy — without disturbing its other reactive chemical groups.
- Beyond drug development, the reaction opens pathways in protein science (understanding sulphur-containing amino acids) and sustainable materials science (recyclable polymers that can be unmade on demand).
- Scientists described the discovery as a "major discovery" after years of research, as sulphur-sulphur bond rearrangements were previously thought to require energetic input.
Static Topic Bridges
Sulphur Chemistry in Biology and Medicine
Sulphur is the third most abundant mineral in the human body and plays a central role in biochemistry. Sulphur-containing amino acids — cysteine and methionine — are critical structural and functional components of proteins.
- Disulfide bonds (S-S bonds between two cysteine residues) are among the most important post-translational modifications in proteins: they stabilise protein 3D structure and regulate enzyme activity.
- Trisulfides (three sulphur atoms in sequence: -S-S-S-) occur naturally in garlic (allicin-related compounds) and in some anticancer natural products like calicheamicin.
- Calicheamicin: a highly potent natural antibiotic and anti-tumour molecule isolated from the bacterium Micromonospora echinospora; it is the warhead in the FDA-approved drug gemtuzumab ozogamicin (Mylotarg) used in acute myeloid leukaemia (AML) treatment.
- Sulphur-containing drugs constitute approximately 25–30% of FDA-approved small molecule drugs — reflecting sulphur's pharmacological versatility.
Connection to this news: The trisulfide metathesis reaction provides a new, mild, selective tool to modify sulphur-containing drug molecules — including calicheamicin — without damaging the rest of the molecule, directly accelerating development of more targeted therapeutics.
Drug Development Process — How New Chemistry Enables New Medicines
Drug development is a multistep process from target identification to clinical approval. New chemical reactions expand the toolkit available to medicinal chemists in the lead optimisation phase.
- The six stages of drug development: Target Identification → Lead Discovery → Lead Optimisation → Pre-clinical Testing → Clinical Trials (Phase I, II, III) → Regulatory Approval.
- Medicinal chemistry relies on reactions that are selective, mild, and compatible with complex biological molecules — the trisulfide metathesis reaction fits all three criteria.
- Antibody-Drug Conjugates (ADCs) — a major growth area in oncology — use sulphur chemistry (cysteine conjugation) to attach toxic drug payloads to cancer-targeting antibodies; new sulphur reactions directly improve ADC design.
- India's pharmaceutical sector (world's largest generic drug producer) would benefit from access to novel synthetic routes that simplify modification of complex natural product-based drugs.
- CSIR (Council of Scientific and Industrial Research) and IICT (Indian Institute of Chemical Technology, Hyderabad) are India's primary institutions for new chemical synthesis research relevant to pharma.
Connection to this news: The trisulfide metathesis discovery is not just academic — it provides a practical synthetic shortcut that pharmaceutical researchers worldwide, including in India, can use to modify complex drug molecules more efficiently.
Green Chemistry and Sustainable Synthesis
The trisulfide metathesis reaction aligns with green chemistry principles: it operates at room temperature, requires no added reagents or external energy, and generates minimal waste.
- The 12 Principles of Green Chemistry (Anastas and Warner, 1998) emphasise atom economy, waste prevention, catalytic over stoichiometric reactions, and energy efficiency.
- Room-temperature reactions reduce energy consumption in industrial synthesis — a key metric for pharmaceutical manufacturing sustainability.
- Recyclable plastics application: the same trisulfide metathesis chemistry enables polymers that can be moulded, used, and then "unmade" for recycling — addressing plastic waste at the molecular design stage.
- India's National Chemical Policy (2019, draft) and the Chemical & Petrochemicals sector under the Department of Chemicals and Petrochemicals recognise green chemistry as a national priority.
Connection to this news: The discovery's application in recyclable plastics alongside drug development illustrates the cross-sector impact of fundamental chemistry breakthroughs — directly relevant to both pharmaceutical and environmental policy.
Key Facts & Data
- Discovery: Trisulfide metathesis reaction — spontaneous sulphur-sulphur bond exchange at room temperature.
- Published: Nature Chemistry (2026).
- Lead researchers: Professor Justin Chalker, Flinders University, Australia; collaborators at University of Liverpool.
- Application demonstrated: Modification of calicheamicin (anti-tumour compound) within ~10 minutes at room temperature.
- Calicheamicin: natural product from Micromonospora echinospora; used in FDA-approved drug Mylotarg (gemtuzumab ozogamicin) for acute myeloid leukaemia.
- Sulphur-containing drugs: ~25–30% of FDA-approved small molecule drugs.
- Reaction conditions: No reagents, no catalysts, no heat or light required — spontaneous in polar aprotic solvents.
- Green chemistry benefit: Energy-efficient, minimal waste, compatible with complex molecules.